Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 101.28%5.65B | -29.58%2.81B | 30.44%3.99B | -10.72%3.06B | 15.91%3.43B | 12.96%2.96B | 6.64%2.62B | -51.54%2.45B | 39.91%5.06B | -4.13%3.62B |
Net profit before non-cash adjustment | 44.48%5.2B | 38.85%3.6B | 30.32%2.59B | 9.77%1.99B | 82.85%1.81B | 255.20%991M | -72.97%279M | -50.24%1.03B | -39.95%2.07B | 5.92%3.45B |
Total adjustment of non-cash items | 20.07%1.96B | 2.13%1.63B | 15.36%1.6B | 3.74%1.39B | -9.17%1.34B | -13.05%1.47B | -0.99%1.69B | -7.22%1.71B | 25.63%1.84B | 2.95%1.47B |
-Depreciation and amortization | 8.72%1.97B | 21.69%1.81B | 13.58%1.49B | -3.32%1.31B | -3.07%1.36B | -16.03%1.4B | 0.30%1.67B | -1.89%1.66B | 27.20%1.69B | 4.47%1.33B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | --26M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 836.84%178M | 272.73%19M |
-Share of associates | ---- | ---- | ---- | ---- | --0 | -50.00%1M | --2M | --0 | 266.67%11M | --3M |
-Disposal profit | 32.88%97M | 4.29%73M | -10.26%70M | 90.24%78M | 5.13%41M | -27.78%39M | 86.21%54M | -38.30%29M | -30.88%47M | -62.22%68M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -306.67%-31M | --15M |
-Other non-cash items | 58.17%-105M | -1,773.33%-251M | 850.00%15M | 96.67%-2M | -281.82%-60M | 213.79%33M | -245.00%-29M | 136.36%20M | -277.42%-55M | 272.22%31M |
Changes in working capital | 37.79%-1.51B | -1,076.70%-2.42B | 34.81%-206M | -216.18%-316M | -44.26%272M | -24.22%488M | 323.61%644M | -125.15%-288M | 187.87%1.15B | -42.87%-1.3B |
-Change in receivables | 39.29%-513M | 17.32%-845M | -809.72%-1.02B | 357.14%144M | 86.00%-56M | -525.00%-400M | -131.07%-64M | -86.10%206M | 221.38%1.48B | -97.57%-1.22B |
-Change in inventory | -2.25%-1.82B | -1,514.55%-1.78B | 74.71%-110M | -215.22%-435M | -230.19%-138M | -87.91%106M | 332.63%877M | -1,042.50%-377M | 106.42%40M | 12.25%-623M |
-Change in payables | 635.29%1B | -83.89%136M | 1,017.39%844M | -154.76%-92M | 7.01%168M | 165.97%157M | -357.69%-238M | 80.23%-52M | -169.58%-263M | -12.90%378M |
-Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -169.94%-114M | 1,005.56%163M |
-Provision for loans, leases and other losses | -393.44%-179M | -25.61%61M | 22.39%82M | -77.52%67M | -52.32%298M | 805.80%625M | 291.67%69M | ---36M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---29M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 0.00%-1M | 0.00%-1M | 0.00%-1M | 0.00%-1M | 0.00%-1M | 0.00%-1M | 0.00%-1M | 0.00%-1M | 50.00%-1M | 0.00%-2M |
Interest received (cash flow from operating activities) | 25.00%5M | -33.33%4M | -40.00%6M | 0.00%10M | -28.57%10M | 7.69%14M | 0.00%13M | -13.33%13M | 25.00%15M | -7.69%12M |
Tax refund paid | -92.96%-1.29B | 5.38%-668M | -3.52%-706M | 16.11%-682M | -392.73%-813M | 23.61%-165M | 57.65%-216M | 56.52%-510M | 9.98%-1.17B | -20.54%-1.3B |
Other operating cash inflow (outflow) | 0 | 0 | 0 | -1M | 0 | -1M | 0 | 0 | -200.00%-1M | 200.00%1M |
Operating cash flow | 103.78%4.37B | -34.79%2.14B | 37.92%3.29B | -9.04%2.38B | -6.46%2.62B | 16.17%2.8B | 23.44%2.41B | -49.92%1.95B | 67.76%3.9B | -13.95%2.33B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 9.49%-1.87B | 37.07%-2.07B | -27.00%-3.28B | -35.20%-2.59B | -20.18%-1.91B | -54.17%-1.59B | 32.02%-1.03B | 7.33%-1.52B | 25.55%-1.64B | 13.93%-2.2B |
Net intangibles purchase and sale | 15.63%-27M | -128.57%-32M | 41.67%-14M | 70.37%-24M | 56.68%-81M | -523.33%-187M | -36.36%-30M | 38.89%-22M | 7.69%-36M | 65.49%-39M |
Net investment product transactions | --0 | --0 | ---4B | --0 | --40M | ---- | ---- | ---- | ---- | ---600M |
Net changes in other investments | 0.00%-14M | -136.84%-14M | 3,900.00%38M | 66.67%-1M | 78.57%-3M | -250.00%-14M | -233.33%-4M | 117.65%3M | 70.18%-17M | -58.33%-57M |
Investing cash flow | 9.52%-1.91B | 70.91%-2.11B | -178.12%-7.26B | -33.44%-2.61B | -9.15%-1.96B | -68.11%-1.79B | 30.64%-1.07B | 9.11%-1.54B | 41.61%-1.69B | -7.06%-2.9B |
Financing cash flow | ||||||||||
Net common stock issuance | -250.00%-7M | 0.00%-2M | -100.00%-2M | 66.67%-1M | 0.00%-3M | 0.00%-3M | -50.00%-3M | 33.33%-2M | 40.00%-3M | -66.67%-5M |
Cash dividends paid | -51.69%-1.12B | -45.19%-739M | -25.06%-509M | -22.96%-407M | -8.17%-331M | 14.29%-306M | 17.55%-357M | 5.66%-433M | 0.00%-459M | -12.50%-459M |
Net other fund-raising expenses | -37.50%-22M | -6.67%-16M | 6.25%-15M | -33.33%-16M | -9.09%-12M | 0.00%-11M | 15.38%-11M | -8.33%-13M | 7.69%-12M | -8.33%-13M |
Financing cash flow | -51.92%-1.15B | -43.92%-757M | -24.06%-526M | -22.54%-424M | -8.13%-346M | 13.75%-320M | 17.19%-371M | 5.49%-448M | 0.63%-474M | -12.77%-477M |
Net cash flow | ||||||||||
Beginning cash position | -13.47%4.39B | -47.85%5.07B | -5.79%9.72B | 3.14%10.32B | 7.36%10.01B | 11.21%9.32B | -1.37%8.38B | 25.62%8.5B | -11.93%6.76B | -2.61%7.68B |
Current changes in cash | 280.41%1.31B | 83.88%-725M | -591.85%-4.5B | -303.76%-650M | -53.77%319M | -29.23%690M | 3,245.16%975M | -101.78%-31M | 265.90%1.74B | -146.35%-1.05B |
Effect of exchange rate changes | -39.02%25M | 126.62%41M | -390.57%-154M | 1,425.00%53M | -33.33%-4M | 91.18%-3M | 60.00%-34M | -2,733.33%-85M | -102.27%-3M | -39.45%132M |
Cash adjustments other than cash changes | ---- | 200.00%1M | ---1M | ---- | 0.00%-1M | 50.00%-1M | ---2M | ---- | 0.00%-1M | -200.00%-1M |
End cash Position | 30.39%5.72B | -13.47%4.39B | -47.85%5.07B | -5.79%9.72B | 3.14%10.32B | 7.36%10.01B | 11.21%9.32B | -1.37%8.38B | 25.62%8.5B | -11.93%6.76B |
Free cash flow | 5,627.91%2.46B | 577.78%43M | 96.00%-9M | -135.89%-225M | -38.77%627M | -24.09%1.02B | 225.85%1.35B | -81.42%414M | 2,521.18%2.23B | 165.63%85M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |